Purpose

This study aims to compare the efficacy of a one-time IM dose of dexamethasone versus a 5-day course of prednisone in adult ED patients presenting with asthma exacerbations. This is a randomized, controlled, double-blind, non-inferiority trial conducted at two urban EDs within the Montefiore Health System.

Condition

Eligibility

Eligible Ages
Over 18 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Adults ≥18 years old presenting to the ED with an asthma exacerbation - Diagnosed with asthma per International Classification of Diseases, 10th Revision (ICD-10) criteria or by the treating clinician - Discharged from the ED with a primary diagnosis of asthma exacerbation - Initiated systemic corticosteroids during the ED visit - Must be English or Spanish speaking

Exclusion Criteria

  • Current use of systemic corticosteroids, including Emergency Medical Services (EMS) administration before ED arrival - History of severe adverse reactions to corticosteroids - Heart failure and uncontrolled diabetes (glucose >300mg/dL in the ED) - Pregnancy or breastfeeding as prednisone is the preferred treatment for asthma in this population - Inability to provide informed consent

Study Design

Phase
Phase 4
Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel Assignment
Intervention Model Description
Participants will be randomly assigned 1:1 to a treatment group using a computer-generated randomization schedule.
Primary Purpose
Treatment
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Masking Description
Participants, treating physicians, nursing, and the investigators will remain blinded to treatment allocation. Blinded medications will be pre-packaged by the clinical research pharmacy team.

Arm Groups

ArmDescriptionAssigned Intervention
Active Comparator
Single Intramuscular Steroid Injection
Dexamethasone 16mg Intramuscular Single Dose
  • Drug: Dexamethasone 16mg IM
    Dexamethasone 16mg Intramuscular Administration Once
Active Comparator
Oral Steroid Short Course
Prednisone 60mg PO for 5 Days
  • Drug: Prednisone 60mg PO
    Prednisone 60mg PO for 5 Days

Recruiting Locations

Montefiore Medical Center
The Bronx, New York 10467
Contact:
Mustfa Manzur, MD MPH MS
718-920-6626
mmanzur@montefiore.org

More Details

Status
Recruiting
Sponsor
Montefiore Medical Center

Study Contact

Mustfa Manzur, MD MPH MS
718-920-6626
mmanzur@montefiore.org

Detailed Description

Asthma exacerbations are a leading cause of emergency department (ED) visits in the United States. In pediatric patients, a single dose of dexamethasone has been widely adopted as an effective and convenient alternative to multi-day oral steroid regimens. However, in adults, evidence regarding the efficacy of a single-dose steroid approach compared to a traditional 5-day course of oral prednisone is mixed. Despite the availability of oral corticosteroids like prednisone, medication adherence after ED discharge remains a significant challenge. Studies indicate that only about 30% of ED patients fill prescribed medications post-discharge. A single-dose intramuscular (IM) dexamethasone regimen offers the advantage of ensuring adequate anti-inflammatory effects for asthma exacerbations. This study aims to compare the efficacy of a one-time IM dose of dexamethasone versus a 5-day course of prednisone in adult ED patients presenting with asthma exacerbations.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.